Genzyme Corp. has recalled several lots of the transplant anti-rejection drug thymoglobulin, after one lot failed a periodic stability test.
Ivabradine May Reduce HF Readmissions – MedPage Today
Ivabradine May Reduce HF ReadmissionsMedPage TodayIvabradine (Procoralan) added to standard heart failure therapy reduced HF readmissions by a third in patients with systolic heart failure compared with patients on standard treatment, according to a po…
Genzyme recalls transplant drug – Mass High Tech
Genzyme recalls transplant drugMass High TechThymoglobulin is given to kidney transplant patients to treat acute rejection of the organ, and is given in conjunction with immunosuppression therapy. The recall was launched on August 2, and the affected l…
Inspra® reduces risk of recurrent heart failure hospitalisation – Pharmacy Europe
Inspra® reduces risk of recurrent heart failure hospitalisationPharmacy EuropeResults of this sub-analysis showed that despite fewer deaths in the eplerenone group compared with placebo, there were fewer recurrent hospitalisations. Heart failure hospi…
Good Outlook for Heart Failure Patients Given Ventricular Restoration Device – TCTMD
TCTMDGood Outlook for Heart Failure Patients Given Ventricular Restoration DeviceTCTMDMUNICH, Germany—In patients with ischemic heart failure, percutaneously implanted device that separates healthy and damaged heart muscle and restores ventricle func…
Play God: say yes to organ donation – Sydney Morning Herald
Sydney Morning HeraldPlay God: say yes to organ donationSydney Morning HeraldIn a lecture theatre at Melbourne's Austin Hospital, I quietly wept. Like the others there, I was watching director Paul Cox's The Dinner Party, a documentary about li…
Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure
SAN DIEGO, Aug. 29, 2012 /PRNewswire/ — Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today …
Black Joins Ohio State's Division of Transplant Surgery – PressZoom (press release)
Black Joins Ohio State's Division of Transplant SurgeryPressZoom (press release)COLUMBUS, Ohio – Dr. Sylvester Black has joined The Ohio State University Wexner Medical Center's Division of Transplant Surgery. Black specializes in abdominal t…
Pakistanis trade kidneys for cash – Deutsche Welle
Deutsche WellePakistanis trade kidneys for cashDeutsche WelleKidneys made up 75 percent of the organ trade and the biggest organ trafficking rackets were operating in China, India and Pakistan. In Pakistan, most of the illicit transplantation cases hav…
Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals
Sleep disorders are a large area. We are focused on one particular type of sleep disturbance called “non-restorative” sleep. People with this problem do sleep, but they don’t wake up feeling refreshed or feeling that their sleep has had the resto…